Evaxion Total Assets from 2010 to 2024

EVAX Stock

USD 1.66 0.09 5.73%

Evaxion Biotech Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

12.9 M

Current Value

13.5 M

Quarterly Volatility

20 M

Credit Downgrade

Yuan Drop

Covid

Check Evaxion Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evaxion Biotech's main balance sheet or income statement drivers, such as Interest Income of 1.4 M, Depreciation And Amortization of 330.1 K or Interest Expense of 1 M, as well as many indicators such as Price To Sales Ratio of 206, Dividend Yield of 0.0 or Days Sales Outstanding of 4.3 K. Evaxion financial statements analysis is a perfect complement when working with Evaxion Biotech Valuation or Volatility modules.

Check out the analysis of Evaxion Biotech Correlation against competitors.

Latest Evaxion Biotech's Total Assets Growth Pattern

Below is the plot of the Total Assets of Evaxion Biotech AS over the last few years. Total assets refers to the total amount of Evaxion Biotech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Evaxion Biotech AS books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Evaxion Biotech's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evaxion Biotech's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 12.89 M

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Evaxion Total Assets Regression Statistics

	Arithmetic Mean	4,186,830
	Coefficient Of Variation	476.88
	Mean Deviation	9,736,863
	Median	2,949,000
	Standard Deviation	19,966,104
	Sample Variance	398.6T
	Range	99.1M
	R-Value	0.02
	Mean Square Error	429.2T
	R-Squared	0.0003
	Significance	0.95
	Slope	78,711
	Total Sum of Squares	5581T

Evaxion Total Assets History

	2024	13.5 M
	2023	12.9 M
	2022	-58.9 M
	2021	40.2 M
	2020	12 M
	2019	11.1 M
	2018	8.5 M

Other Fundumenentals of Evaxion Biotech AS

Intangibles To Total Assets

Evaxion Biotech Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Short Term Debt	Common Stock	Net Tangible Assets	Short Long Term Debt	Capital Stock	Property Plant Equipment	Intangible Assets	Long Term Debt	Current Deferred Revenue	Short Term Investments
Total Assets		0.43	-0.15	0.05	0.12	0.25	-0.09	0.16	0.29	0.17	0.06	0.0	0.01	-0.04	0.01	-0.04	-0.08	-0.41	-0.17	-0.17
Total Stockholder Equity	0.43		0.65	0.48	-0.46	0.35	-0.47	-0.77	-0.7	-0.72	0.01	-0.48	-0.58	0.47	-0.47	-0.66	0.31	-0.49	-0.03	-0.03
Net Debt	-0.15	0.65		0.04	-0.42	0.03	0.03	-0.93	-0.81	-0.97	0.12	-0.12	-0.33	0.44	-0.11	-0.23	-0.12	0.17	-0.39	-0.39
Retained Earnings	0.05	0.48	0.04		-0.73	0.63	-0.94	-0.31	-0.51	-0.23	0.07	-0.92	-0.94	0.79	-0.94	-0.95	0.94	-0.91	0.78	0.78
Accounts Payable	0.12	-0.46	-0.42	-0.73		-0.4	0.66	0.55	0.61	0.51	-0.12	0.73	0.81	-0.88	0.73	0.68	-0.55	0.52	-0.36	-0.36
Net Receivables	0.25	0.35	0.03	0.63	-0.4		-0.77	-0.25	-0.36	-0.07	-0.49	-0.54	-0.65	0.64	-0.55	-0.54	0.51	-0.64	0.41	0.41
Total Liab	-0.09	-0.47	0.03	-0.94	0.66	-0.77		0.29	0.49	0.13	0.25	0.84	0.86	-0.7	0.85	0.89	-0.89	0.87	-0.75	-0.75
Net Invested Capital	0.16	-0.77	-0.93	-0.31	0.55	-0.25	0.29		0.95	0.96	0.07	0.36	0.54	-0.56	0.35	0.5	-0.17	0.08	0.14	0.14
Total Current Assets	0.29	-0.7	-0.81	-0.51	0.61	-0.36	0.49	0.95		0.89	0.07	0.5	0.71	-0.67	0.51	0.67	-0.44	0.23	-0.17	-0.17
Net Working Capital	0.17	-0.72	-0.97	-0.23	0.51	-0.07	0.13	0.96	0.89		-0.19	0.3	0.49	-0.53	0.29	0.43	-0.09	0.01	0.2	0.2
Short Term Debt	0.06	0.01	0.12	0.07	-0.12	-0.49	0.25	0.07	0.07	-0.19		-0.09	-0.13	0.16	-0.09	-0.08	0.07	-0.06	0.05	0.05
Common Stock	0.0	-0.48	-0.12	-0.92	0.73	-0.54	0.84	0.36	0.5	0.3	-0.09		0.87	-0.74	1.0	0.89	-0.79	0.85	-0.56	-0.56
Net Tangible Assets	0.01	-0.58	-0.33	-0.94	0.81	-0.65	0.86	0.54	0.71	0.49	-0.13	0.87		-0.93	0.89	0.93	-0.85	0.78	-0.64	-0.64
Short Long Term Debt	-0.04	0.47	0.44	0.79	-0.88	0.64	-0.7	-0.56	-0.67	-0.53	0.16	-0.74	-0.93		-0.75	-0.74	0.64	-0.6	0.45	0.45
Capital Stock	0.01	-0.47	-0.11	-0.94	0.73	-0.55	0.85	0.35	0.51	0.29	-0.09	1.0	0.89	-0.75		0.9	-0.82	0.86	-0.6	-0.6
Property Plant Equipment	-0.04	-0.66	-0.23	-0.95	0.68	-0.54	0.89	0.5	0.67	0.43	-0.08	0.89	0.93	-0.74	0.9		-0.91	0.84	-0.69	-0.69
Intangible Assets	-0.08	0.31	-0.12	0.94	-0.55	0.51	-0.89	-0.17	-0.44	-0.09	0.07	-0.79	-0.85	0.64	-0.82	-0.91		-0.82	0.93	0.93
Long Term Debt	-0.41	-0.49	0.17	-0.91	0.52	-0.64	0.87	0.08	0.23	0.01	-0.06	0.85	0.78	-0.6	0.86	0.84	-0.82		-0.66	-0.66
Current Deferred Revenue	-0.17	-0.03	-0.39	0.78	-0.36	0.41	-0.75	0.14	-0.17	0.2	0.05	-0.56	-0.64	0.45	-0.6	-0.69	0.93	-0.66		1.0
Short Term Investments	-0.17	-0.03	-0.39	0.78	-0.36	0.41	-0.75	0.14	-0.17	0.2	0.05	-0.56	-0.64	0.45	-0.6	-0.69	0.93	-0.66	1.0

Click cells to compare fundamentals

About Evaxion Biotech Financial Statements

Evaxion Biotech investors use historical fundamental indicators, such as Evaxion Biotech's Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Evaxion Biotech. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Total Assets	12.9 M	13.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Evaxion Stock Analysis

When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC